Candidiasis has increased substantially worldwide over recent decades and is a significant
cause of morbidity and mortality, especially among critically ill patients. Diabetes mellitus …

Only five species account for 92% of cases of candidemia (C andida albicans, C. glabrata,
C. tropicalis, C. parapsilosis, and C. krusei); however, their distribution varies in population …

Invasive candidiasis (IC) is a leading cause of mycosis-associated mortality in the United
States. We examined data from the National Center for Health Statistics and reviewed recent …

The incidence of invasive mycoses is increasing, especially among patients who are
immunocompromised or hospitalized with serious underlying diseases. Such infections may …

Candida parapsilosis is an emerging major human pathogen that has dramatically
increased in significance and prevalence over the past 2 decades, such that C. parapsilosis …

Oral microbiota contribute to health and disease, and their disruption may influence the
course of oral diseases. Here, we used pyrosequencing to characterize the oral bacteriome …

Patient characteristics, antifungal prophylaxis, and other factors appear to have contributed
to a change in the spectrum of invasive fungal pathogens. Infections with Candida glabrata …

BACKGROUND. The objective of the current retrospective study was to compare the
epidemiology of candidemia and its risk factors in patients who had hematologic …

Clonal outbreaks of fluconazole-resistant (FLZR) Candida parapsilosis isolates have been
reported in several countries. Despite its being the second leading cause of candidemia, the …

Fungal infections are an increasing cause of morbidity and mortality in hospitalized patients.
This article reviews the current epidemiology of nosocomial fungal infections in adult …